PHOundry Pharmaceuticals' Acquisition

PHOundry Pharmaceuticals was acquired by Intarcia Therapeutics on September 24, 2015.

PHOundry Pharmaceuticals is focusing upon discovery of high-potency, peptidase-resistant peptide therapeutics with high druggability.…

Articles about PHOundry Pharmaceuticals' Acquisition: